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We investigated the expression and localization of high-mobility group box chromosomal protein-1 
(HMGB-1) in human osteoarthritic (OA) cartilage in relation to the histopathological grade of cartilage 
destruction,  and examined the role of HMGB-1 in the regulation of proinﬂammatory cytokine expres-
sion in chondrocytes.  An immunohistochemical study demonstrated that total HMGB-1-positive cell 
ratios increase as the Osteoarthritis Research Society International (OARSI) histological grade 
increased.  The population of cytoplasmic HMGB-1-positive chondrocytes was especially increased in 
the deep layers of higher-grade cartilage.  The ratios and localization of receptors for advanced glyca-
tion end products (RAGE) expression by chondrocytes in Grade 2,  3,  and 4 were signiﬁcantly higher 
than those in Grade 1.  In vitro stimulation with IL-1ｹ,  but not TNFｸ,  signiﬁcantly upregulated the 
expression of HMGB-1 mRNA by human OA chondrocytes.  Both IL-1ｹ and TNFα promoted the trans-
location of HMGB-1 from nuclei to cytoplasm.  IL-1ｹ and TNFｸ secretions were stimulated at higher 
levels of HMGB-1.  The results of our study suggest the involvement of HMGB-1 in the pathogenesis of 
cartilage destruction in OA.
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steoarthritis (OA) is a proliferative joint dis-
ease characterized by articular cartilage degen-
eration,  osteophyte formation,  subchondral bone 
sclerosis,  and secondary induced synovitis [1].  
Although numerous studies have revealed the contri-
bution of genetic factors,  growth factors and cytok-
ines,  mechanical stress,  proteinase,  or altered 
responses of chondrocytes in the progression of OA,  
the pathogenesis of OA has not been fully understood.
　 High-mobility group box chromosomal protein 
(HMGB-1),  previously called HMG-1 or amphoterin,  
named for its rapid mobility on electrophoresis gels,  
is a ubiquitous,  approximately 27-kDa nonhistone 
protein with a highly conserved amino acid sequence 
identity between rodents and humans [2-4].  Nuclear 
HMGB-1 has been widely studied as a deoxyribonu-
cleic acid (DNA)-binding protein.  It participates in the 
maintenance of nucleosomal structure and stability and 
facilitates the binding of transcription factors to their 
cognate DNA sequences [5].  HMGB-1 also has func-
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tions in DNA transcription,  recombination [6,  7],  
repair,  cell replication,  cell migration,  and tumor 
growth [8,  9].
　 In contrast to its intranuclear role,  HMGB-1 plays 
a critical role outside the cell as a proinﬂammatory 
cytokine mediating delayed endotoxin lethality as well 
as acute lung injury in mice [10,  11].  Moreover,  high 
levels of HMGB-1 have been detected in the blood of 
patients with sepsis and in the synovial ﬂuid of rheu-
matoid arthritis (RA) patients [12].  Proinﬂammatory 
mediators,  such as tumor necrosis factor α (TNFα) 
and interleukin-1β (IL-1β),  dose-dependently induce 
the release of HMGB-1 from monocytes and mac-
rophages [10].  Furthermore,  once released,  HMGB-1 
activates an additional downstream cascade by stimu-
lating monocytes to produce proinﬂammatory cytokines 
and chemokines [13].
　 The receptor for advanced glycation end products 
(RAGE) is a transmembrane protein that belongs to the 
immunoglobulin superfamily and is expressed in vascu-
lar smooth muscle cells,  neurons,  and certain phago-
cytes such as monocytes and macrophages [14].  
Recently,  the expression of RAGE has been reported 
in articular chondrocytes,  synoviocytes,  and RA 
synovial macrophages [15-17].  Membrane-associated 
HMGB-1 mediates cellular proliferation and growth by 
signaling through the receptor for RAGE [18].
　 Previous reports have suggested the HMGB-1 
upregulation in OA cartilage and induction of inﬂam-
matory cytokines such as IL-6 or IL-8 [19].  In the 
current study,  we investigated the expression and 
localization of nuclear and cytoplasmic HMGB-1 in 
normal human cartilage and OA cartilage.  We further 
investigated the eﬀect of HMGB-1 stimulation on 
TNFα and IL-1β production,  as well as the eﬀect of 
TNFα and IL-1β on HMGB-1 production by human 
OA chondrocytes.  Our data strongly suggest the 
involvement of HMGB-1 in proinﬂammatory cytokines 
in cartilage destruction.
Materials and Methods
　 Production of HMGB-1-speciﬁc monoclonal 
antibody. Rats were immunized with HMGB-1/
HMGB-2 (Sigma,  St. Louis,  MO,  USA) emulsiﬁed 
with Freundʼs complete adjuvant.  A booster injection 
with incomplete adjuvant was administered to the rats 
3 weeks later.  After conﬁrming the elevation of anti-
HMGB-1 antibody,  we produced hybridomas as previ-
ously described [20].  The epitope recognized by each 
monoclonal antibody was determined by dot blotting,  
using synthetic overlapping peptides derived from a 
human HMGB-1 sequence 15 amino acids long.  The 
clone (Nos. 10-22,  subclass IgG2a) used for the 
experiments recognized the C-terminal sequence of the 
HMGB-1 molecule,  DEDEEEE,  as speciﬁc for 
HMGB-1 but not for HMGB-2.
　 Recombinant human HMGB-1 (rHMGB-1).
rHMGB-1 was produced in Sf9 cells to obtain LPS-
free HMGB-1.  In brief,  full-length human HMGB-1 
DNA was ampliﬁed by PCR using Cap Site cDNA dT 
from human microvascular endothelial cells (Nippon 
Gene,  Tokyo,  Japan) and primers (forward 5ʼ-GCA 
GAA TTC ATG GGC AAA GGA GAT CCT A-3ʼ,  
reverse 5ʼ-CAT CTC GAG TCA TTA TTC ATC 
ATC ATC ATC-3ʼ).  The fragment was digested with 
EcoRI and XhoI and cloned into a pFastBacHTA 
(Invitrogen,  Carlsbad,  CA,  USA) expression vector.  
The transfection of the Sf9 cells with the pFast-
BacHTA-HMGB-1 bacmid was performed according to 
the manufacturerʼs instructions (Bac-to-Bac 
Baculovirus Expression System,  Invitrogen).  The 
infected SF9 cell extract containing His-tagged 
HMGB-1 protein was applied to Ni-NTA agarose 
(Qiagen,  Hilden,  Germany) and incubated for 3 hours 
at room temperature.  After extensive washing,  
rHMGB-1 was eluted with imidazole buﬀer.  The 
rHMGB-1 was collected and dialyzed overnight at 4℃ 
against PBS.  Puriﬁed rHMGB-1 protein was identi-
ﬁed by SDS-PAGE and Western blotting with anti-
HMGB-1 mAb.  The ﬁnal HMGB-1 preparation con-
tained LPS of less than 2.0pg/µg protein.
　 Human cartilage samples. Thirty-one human 
OA cartilage samples were obtained at the time of 
total knee arthroplasty (TKA) surgery from 27 OA 
patients (aged 48 to 82 years; average,  70.7 years),  
who lacked a medical history of other inﬂammatory 
diseases.  Normal cartilage was obtained from 4 
patients with osteosarcoma (aged 9 to 29 years;  
average 15.5 years) who lacked any inﬂammatory dis-
eases at the time of amputation surgery.  Written 
informed consent was obtained from the patients or 
their parents.
　 RNA isolation from OA cartilage. OA car-
tilage samples from OA patients (n＝4) and normal 
cartilage from osteosarcoma patients (n＝4) were 
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divided in half; one half was immediately frozen in 
liquid nitrogen and stored at －180℃ until required 
for RNA isolation.  At that point the frozen articular 
cartilage (10-40mg wet weight) was milled with Micro 
Smash (Tomy Seiko Co,  Tokyo,  Japan) at 2 cycles of 
1min at 4,500 rpm and was suspended in 1mL Isogen 
(Nippon Gene Co,  Tokyo,  Japan).  Total RNA was 
isolated according to the manufacturerʼs protocol.
　 cDNA synthesis and Quantitative Real-Time 
PCR. First-strand cDNA was synthesized from 
1µg total RNA using the ReverTra Ace-α according to 
the manufacturerʼs (Toyobo Co.,  Ltd.,  Osaka,  Japan) 
instructions.  cDNA (1.5µL) was ampliﬁed by real-
time PCR using Brilliant® II SYBR Green QPCR 
Master Mix (Stratagene,  La Jolla,  CA,  USA).  
Quantitative PCR was performed on a 25-µL samples.  
Mixtures were preincubated at 95℃ for 10min,  fol-
lowed by 40 cycles of PCR at 95℃ for 30 sec and 
60℃ for 30 sec,  and normalized to GAPDH.  In 
every case,  the cycle threshold (CT) taken for quanti-
tation was in the linear portion of the ampliﬁcation 
range.  PCR primers were HMGB-1 sense,  5ʼ-TAT 
GAA AAG AAG GCT GCG AAG-3ʼ; and HMGB-1 
antisense,  5ʼ-CTG CGC TAG AAC CAA CTT ATT 
C-3ʼ,  GAPDH sense,  5ʼ-CAT CAA GAA GGT GGT 
GAA GCA G-3ʼ; and GAPDH; antisense,  5ʼ-CTG 
CAA AGG TGG AGG AGT GG-3ʼ.  All PCRs were 
performed in triplicate using the Mx3000P quantita-
tive PCR system (Stratagene).  RNA levels are 
reported as fold changes compared with the control 
using the comparative quantitation analysis software 
available with the Mx3000P.  Changes in expression 
(fold) for HMGB-1 were calculated as 2－Δ(ΔCT),  where 
ΔCT= CT(target)－CT(housekeeping),  and Δ(ΔCT)＝
ΔCT (treated)－ΔCT(control).  Reaction product 
purity was conﬁrmed by examination of the melting 
curves for a single peak.
　 Immunohistochemistry for HMGB-1 and 
RAGE. Twenty-seven OA and 4 normal cartilage 
specimens were used in an immunohistochemical study 
for HMGB-1 and RAGE.  The samples were immedi-
ately ﬁxed in 4ｵ paraformaldehyde in 0.1M phos-
phate-buﬀered saline (PBS),  decalciﬁed in 0.3M 
EDTA (pH7.5) for 2-3 weeks,  and embedded in par-
aﬃn.  All sections were used for the histological and 
immunohistochemical studies.
　 The paraﬃn sections were soaked in xylene to be 
deparaﬃnized,  then dehydrated in a graded alcohol 
series (50-100ｵ).  Antigen retrieval was performed 
by autoclaving for 5min at 97℃.  After it was cooled,  
endogenous peroxidase activity was blocked by treat-
ment with 0.3ｵ H2O2 in PBS at room temperature 
for 30min.  It was then incubated with either rat 
monoclonal anti-HMGB-1 antibody (10µg/mL) or goat 
anti-RAGE polyclonal antibody (10µg/mL) (Chemicon,  
Temecula,  CA,  USA) with PBS/bovine serum albu-
min (BSA) overnight at 4℃.  After washing,  the 
slides were incubated with biotinylated anti rat IgG 
antibody diluted 1 : 200 with PBS.  After rinsing in 
PBS,  the specimens were incubated with avidin-
biotinylated enzyme complex (ABC) reagent 
(Vectastain Elite ABC Kit,  Vector Laboratories,  
Burlingame,  CA,  USA),  then washed with distilled 
water.  For RAGE,  a chemical reagent marketed as 
Histoﬁne Simple Stain MAX PO (G) (Nichirei 
Biosciences,  Tokyo,  Japan) was applied as a second-
ary antibody at room temperature for 30min.  The 
reaction was visualized by diaminobenzidine,  which 
turned brown,  after which the samples were counter-
stained with hematoxylin.
　 Quantitative analysis for HMGB-1 and 
RAGE-positive cells. Immunoreactivity was 
evaluated by light microscopy.  The chondrocytes with 
deﬁnite,  diﬀusely stained cytoplasm or nuclei were 
regarded as positively stained.  The populations of 
HMGB-1-positive,  or RAGE-positive cells in the 
superﬁcial,  middle,  and deep layers of OA cartilage,  
were quantiﬁed by counting the number of the cells 
within the 3 layers.  Cell counts were performed in at 
least 3 ﬁelds,  at ×100 magniﬁcation,  and then aver-
aged.  Judgment was based on the consensus of at 
least 2 of the authors (C.T.  and A.Y. ) without refer-
ence to the patientsʼ clinical information.  The number 
of positive chondrocytes was divided by the total 
number of chondrocytes within all 3 layers to calculate 
the positive chondrocyte ratio.  The marginal areas 
between each layer were avoided for cell counting to 
reduce inter-observer errors.  All sections were also 
stained with Safranin O and observed by light micros-
copy.  Histological classiﬁcation of the severity of OA 
lesions was graded 1-6,  using the OARSI cartilage 
OA histopathology grading system reported by 
Pritzker et al. [21].
　 Chondrocyte isolation from OA cartilage.
For the in vitro study,  OA cartilage samples were 
obtained from another 6 sets of patients at TKA.  The 
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ages of patients ranged from 62 to 88 years (mean ± 
SEM 72.1±8.2 years).  Chondrocytes were isolated 
by digestion of cartilage specimens in 0.1ｵ chy-
motrypsin (Wako Pure Chemical Industries,  Osaka,  
Japan) and 0.2ｵ collagenase (Sigma,  St. Louis,  MO,  
USA) following the method of Bruckner et al. [22].  
Chondrocytes were seeded in 6 - well plates (5×104/
mL),  cultured in 3mL Dulbeccoʼs modiﬁed Eagle 
medium (Wako Pure Chemical Industries,  Osaka,  
Japan) containing 10ｵ fetal bovine serum,  100U/mL 
penicillin (Wako Pure Chemical Industries,  Osaka,  
Japan),  and 100µg/mL streptomycin (Wako Pure 
Chemical Industries,  Osaka,  Japan),  and incubated in 
a 5ｵ CO2 humidiﬁed incubator at 37℃ for 14 days 
before starting the experiments.
　 Quantiﬁcation of IL-1β and TNFα produc-
tion by HMGB-1-stimulated chondrocytes.
After exposure of the cells by recombinant human 
HMGB-1 (10,  100,  and 1,000ng/mL) (Biological 
Industries,  Kibbutz,  Israel) for 6,  12,  and 24h,  the 
concentrations of IL-1β and TNFα in the supernatant 
were measured using a commercially available enzyme-
linked immunosorbent assay (ELISA) kit (R&D 
Systems,  Minneapolis,  MN,  USA),  following the 
manufacturerʼs protocol.
　 Quantitative Real-Time PCR for HMGB-1 
mRNA in cytokine-stimulated chondrocytes.
Recombinant human IL-1β and TNFα were purchased 
from R&D Systems.  The cytokines were stored at 
－180℃ and diluted in a culture medium immediately 
before being used.  Total RNA was isolated from pri-
mary OA chondrocytes after treatment with IL-1β 
(10ng/mL) and TNFα (1ng/mL) for 0,  12,  and 24h.  
HMGB-1 mRNA expression was analyzed by real-time 
PCR as previously described.
　 Immunocytochemistry for HMGB-1 in 
cytokine-stimulated chondrocytes. Primary 
cultured OA chondrocytes were treated with IL-1β 
(10ng/mL) and TNFα (1ng/mL) for 48h,  and the 
distribution of the HMGB-1 protein was investigated 
by immunocytochemistry.  Cells were ﬁxed in 4ｵ 
paraformaldehyde for 10min,  blocked with 1ｵ BSA 
for 10min at room temperature,  then incubated with 
an anti-HMGB-1 antibody (1µg/mL) for 30min at room 
temperature.  A BSA solution without the primary 
antibody was used as a negative control.  Alexa Fluor 
488-conjugated antibody (Molecular Probes,  Eugene,  
OR,  USA) and Alexa-Fluor 594-conjugated phalloidin 
(Molecular Probes),  both incubated for 30min at 
room temperature,  and Hoechst 33342 (ICN 
Biomedicals,  Aurora,  OH,  USA),  incubated for 5min 
at room temperature,  were used for detection.  
Fluorescence images were captured using an inverted 
Leica DMRIII microscope (Leica,  Bannockburn,  IL,  
USA) equipped with epiﬂuorescence ﬁlters and a 
charge-coupled device camera using Leica CW4000 
software.
　Statistical analysis. Statistical comparisons 
were made by Mann-Whitney U test using Stat-view 
software.  All values are expressed as means ± SEM.  
P values less than 0.05 were considered signiﬁcant.
Results
　 Expression of HMGB-1 in OA cartilage.
HMGB-1 was detected in normal and OA cartilage at 
both the mRNA and protein level.  HMGB-1 mRNA 
expression was signiﬁcantly higher in OA cartilage 
than in normal cartilage (Fig.  1).
　 Expression and localization of HMGB-1 in 
OA cartilage. The protein expression of HMGB-1 
was seen in all 27 OA cartilage samples (Fig.  2).  
HMGB-1-positive cell ratios relevant to the OA histo-
pathology were 12.6ｵ in Grade 1,  20.1ｵ in Grade 2,  
21.8ｵ in Grade 3,  and 34.2ｵ in Grade 4 (Fig.  3A).  
In Grades 2,  3,  and 4,  HMGB-1-positive cell ratios 
were signiﬁcantly higher than that in Grade 1.  There 
was no signiﬁcant diﬀerence between ratios in Grade 
2 and 3.  In Grade-4 OA,  the HMGB-1-positive cell 


























Fig. 1　 Expression of HMGB-1 in OA cartilage.  HMGB-1 expres-
sion in normal cartilage (n＝4) and OA cartilage (n＝4).  HMGB-1 
mRNA was signiﬁcantly expressed.  ＊p＜0.05 vs. normal (p＝
0.043).
ratio was signiﬁcantly higher than those in Grade 2 or 
3 (Fig.  3A).  The cytoplasmic HMGB-1-positive cell 
rates were 1.4ｵ in Grade 1,  2.3ｵ in Grade 2,  11.1ｵ 
in Grade 3,  and 13.4ｵ in Grade 4.  In Grades 3 and 
4,  the cytoplasmic HMGB-1-positive cell ratios were 
signiﬁcantly higher than those in Grade 1 and 2,  
respectively (Fig.  3A).  There was no signiﬁcant dif-
ference in ratios between Grade 1 and 2,  or between 
Grade 3 and 4.
　 Expression of RAGE in OA cartilage. We 
also investigated RAGE expression in OA cartilage by 
immunohistochemical analysis.  The RAGE-positive 
cell ratios relevant to OA histopathology were 20.4ｵ 
in Grade 1,  36.6ｵ in Grade 2,  37.3ｵ in Grade 3,  
and 35.3ｵ in Grade 4 (Fig.  3B).  The ratios of RAGE 
expression by chondrocytes in Grade 2,  3,  and 4 were 
signiﬁcantly higher than those in Grade 1 (Fig.  3B).  
There was no signiﬁcant diﬀerence among ratio in 
Grades 2,  3,  and 4.  (Fig.  3B).
　 Eﬀect of proinﬂammatory cytokines on 
HMGB-1 expression and localization in OA 
chondrocytes. IL-1β (10ng/mL) signiﬁcantly up-
regulated the expression of HMGB-1 mRNA up to 24h 
by OA chondrocytes (Fig.  4A); however,  TNFα 
(1ng/mL) up-regulation of HMGB-1 mRNA did not 
reach signiﬁcance.  The change in localization of 
HMGB-1 after treatment with IL-1β and TNFα was 
examined by immunocytochemistry.  In the unstimu-
lated group,  HMGB-1 was localized in the nucleus 
(Fig.  4B).  However,  HMGB-1 was translocated from 

















































































Fig. 2　 Immunohistochemistry for HMGB-1 and RAGE.  Expression and localization of HMGB-1 and RAGE in OA cartilage in relation to 
the level of cartilage destruction.  Twenty-seven OA and 4 normal cartilage specimens were used for the immunohistochemical study of 
HMGB-1 and RAGE.  HMGB-1 was expressed in the nucleus.  The cytoplasmic HMGB-1-positive cell rate tended to increase as the OARSI 
grade increased.  RAGE was expressed in the cytoplasm,  and the RAGE-positive cell ratio tended to be higher according to the OARSI 
grade,  as with HMGB-1.  Arrow heads indicate nuclear HMGB-1- and RAGE-positive cells,  and arrows indicate cytoplasmic HMGB-1-
positive cells.  Inset a,  b and c show the superﬁcial,  middle and deep layer,  respectively.























































Fig. 3　 Population of HMGB-1-and RAGE positive chondrocytes.  (A) Cytoplasmic HMGB-1-positive cell ratios tended to be higher in the 
specimens having the higher OARSI grade.  (a,  p＜0.05 vs.  Grade 1; b,  p＜0.05 vs.  Grade 2; c,  p＜0.05 vs.  Grade 3.),  (B) The ratios 
and localization of RAGE expression by chondrocytes in Grades 2,  3 and 4 were signiﬁcantly higher than those in Grade 1.  There was no 

































Fig. 4　 Eﬀect of IL-1β and TNFα on HMGB-1 and localization in OA chondrocyte.  Expression of HMGB-1 mRNA by real-time PCR.  
Cultured chondrocytes were stimulated with IL-1β (10ng/µL),  and total RNA was isolated.  Up-regulation of HMGB-1 was still increasing 
after 12h,  but not TNFα (A).  (＊p＜0.05 vs.  0h (p＝0.033),  ＊＊p＜0.05 vs.  12h (p＝0.002),  NS＝not signiﬁcant.) Translocation of 
HMGB-1 in chondrocytes after IL-1β and TNFα stimulation.  The immunoﬂuorescence assay indicated that HMGB-1was translocated from 
the nucleus to the cytosol following stimulation with both IL-1β and TNFα (B).  Chondrocytes were stimulated with IL-1β (10ng/mL) and 
TNFα (1ng/mL) for 48h and then compared with unstimulated chondrocytes.  Chondrocytes stimulated with IL-1β or TNFα exhibited 
HMGB-1 staining in the cytosol.  Note that unstimulated chondrocytes exhibited HMGB-1 staining only in the nucleus.
the nucleus to the cytosol after stimulation by IL-1β 
(10ng/mL) and TNFα (1ng/mL) at 48h.
　 Eﬀect of HMGB-1 on IL-1β and TNFα 
release by chondrocytes. The eﬀects of HMGB-1 
on IL-1β and TNFα production by chondrocytes were 
analyzed by ELISA.  HMGB-1 stimulated the produc-
tion of IL-1β up to 24h (Fig.  5A),  and 1,000ng/mL 
of HMGB-1 signiﬁcantly up-regulated the production 
of IL-1β by OA chondrocytes at 12h (Fig.  5B).  Peak 
TNFα levels after stimulation with HMGB-1 (100ng/
mL) occurred at 12h and tended to decrease for 24h 
thereafter.  (Fig.  5C).  At 12h,  the amount of TNFα 
released into the cultured medium increased in a dose-
dependent manner after stimulation by HMGB-1 (Fig.  
5D).
Discussion
　 A previous report demonstrated the signiﬁcant 
increase of HMBG-1 mRNA expression in human OA 
cartilage as compared with normal cartilage [19].  In 
the present study,  we examined the expression and 
localization of HMGB-1 in OA cartilage.  Our results 
conﬁrmed that HMGB-1 expression in OA cartilage 
was signiﬁcantly higher than that in the normal carti-
lage for both mRNA and protein levels.  In the immu-
nohistochemical analysis,  it was revealed that the 
HMGB-1-positive cell ratio and cytoplasmic HMGB-1 
positive cell ratio tended to increase along with the OA 
histological grade,  but the nuclear HMGB-1 positive 
cell ratio was unchanged.  These results coincide with 
a report of Heinola et al. in which they studied bovine 

























































Fig. 5　 Eﬀect of HMGB-1 on IL-1β and TNFα expression by human chondrocytes.  Chondrocytes were stimulated with HMGB-1,  and 
ELISA was used to measure levels of IL-1β and TNFα.  After stimulation with HMGB-1 (100ng/mL),  IL-1β levels increased in a time-
dependent manner (A).  IL-1β was released in a dose-dependent manner for 24h after stimulation with HMGB-1,  and the amount of IL-1β 
and TNFα production increased signiﬁcantly at doses of ＞100ng/mL (B).  The peak TNFα levels after stimulation with HMGB-1 (100ng/
mL) occurred at 12h and tended to decrease at 24h (C).  TNFα was released in a dose-dependent manner after stimulation for 12h (D).  
(A) ＊p＜0.05 vs.  0h (p＝0.025).  (C) ＊p＜0.05 vs.  0h (p＝0.039),  ＊＊p＜0.05 vs.  0h (p＝0.018).
cartilage [23].
　 It is not fully understood what stimulates HMGB-1 
production or cytoplasmic translocation from the 
nucleus in chondrocytes.  In normal joint cartilage,  
HMGB-1 has been reported to be located in the nuclei 
of chondrocytes and synovial cells [12].  However,  in 
inﬂammatory synovial cells,  HMGB-1 shows both 
nuclear and cytoplasmic distribution [12].  It was also 
shown that TNFα stimulation caused translocation of 
HMGB-1 from the nucleus to the cytosol in CD68-
positive cells [14].  In the present study,  we demon-
strated that IL-1β but not TNFα up-regulated the 
expression of HMGB-1 at mRNA levels.  Treatment 
with both IL-1β and TNFα caused translocation of 
HMGB-1 from the nucleus to the cytosol 48h after 
stimulation.
　 On the other hand,  previous studies have demon-
strated that extracellular HMGB-1 induced the pro-
duction of IL-1β,  TNFα,  and IL-6 in macrophages 
[10,  14].  Intra-articular injection of HMGB-1 into 
murine knee joints resulted in synovitis,  but mice 
rendered deﬁcient in the IL-1 receptor did not develop 
synovitis after injection.  These results suggest that 
HMGB-1 is not a mere expression of the inﬂammatory 
response,  but a trigger for joint inﬂammation by 
activating macrophages and inducing production of IL-1 
via NF-κB activation [13].  In the current study,  
IL-1β and TNFα production by OA chondrocytes was 
stimulated by HMGB-1 in a dose-dependent manner.  It 
is speculated that proinﬂammatory cytokines stimulate 
the expression and release of HMGB-1 by chondro-
cytes and that the HMGB-1 released by chondrocytes 
further promotes the expression of proinﬂammatory 
cytokines [14].  This speculation is supported by our 
current result that the HMGB-1-positive cell ratio 
increases along with the OA cartilage grade.  It is 
reported that the combination of HMGB-1 and heparin 
induced marked angiogenesis in a heparin-dependent 
manner [24].  The HMGB-1 increase in the deep lay-
ers of OA cartilage might be related to angiogenesis 
at the osteochondral junction.
　 RAGE and toll-like receptors 2 and 4 are known 
ligands of HMGB-1 [25].  RAGE has been found to be 
expressed in cartilage [16] and RA synovium [14];  
however,  RAGE and HMGB-1 do not have a one-to-
one correspondence.  A study reported by Loeser et al. 
[16] showed that RAGE expression was higher in OA 
cartilage than in normal cartilage.  Our immunohis-
tochemical results also demonstrated that expression 
of RAGE was signiﬁcantly higher in cartilage with 
Grades 2,  3,  and 4 OA than that in Grade 1 carti-
lage.  In a separate experiment we used 5 other human 
OA cartilage specimens to perform double immunohis-
tochemistry for HMGB-1 and RAGE to clarify the 
interrelationship of the 2 proteins.  The result showed 
that some populations of chondrocytes showed a posi-
tive reaction only for HMGB-1 or for RAGE,  whereas 
some were positive for both HMGB-1 and RAGE 
(data not shown).  These ﬁndings suggest that HMGB-1 
might act on chondrocytes in both an autocrine and 
paracrine manner.  Stimulation of RAGE signaling 
from HMGB-1 might lead to upregulation of catabolic 
enzymes such as matrix metalloproteinase 13 produc-
tion and contribute to cartilage matrix degradation in 
arthritis [16].
　In conclusion,  we demonstrated the increased 
expression of HMGB-1 in OA cartilage relevant to the 
histological OA grade.  In vitro experiments using 
human OA chondrocytes suggested the close interrela-
tionship between HMGB-1 and IL-1β.  These results 
indicate the possible involvement of the proinﬂamma-
tory cytokine-HMGB-1-RAGE cascade in the develop-
ment of human osteoarthritis.  Whether the blockade 
of this cascade could contribute to the moderation of 
cartilage degeneration requires further investigation.
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